Bank of New York Mellon’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,024
| Closed | -$8K | – | 4603 |
|
|
2022
Q3 | $8K | Hold |
30,024
| – | – | ﹤0.01% | 4521 |
|
|
2022
Q2 | $23K | Hold |
30,024
| – | – | ﹤0.01% | 4483 |
|
|
2022
Q1 | $32K | Hold |
30,024
| – | – | ﹤0.01% | 4580 |
|
|
2021
Q4 | $57K | Hold |
30,024
| – | – | ﹤0.01% | 4480 |
|
|
2021
Q3 | $90K | Buy |
30,024
+19,101
| +175% | +$68K | ﹤0.01% | 4352 |
|
|
2021
Q2 | $43K | Sell |
10,923
-81,479
| -88% | -$338K | ﹤0.01% | 4345 |
|
|
2021
Q1 | $468K | Buy |
92,402
+17,126
| +23% | +$88.8K | ﹤0.01% | 3722 |
|
|
2020
Q4 | $308K | Buy |
75,276
+1,577
| +2% | +$7.75K | ﹤0.01% | 3820 |
|
|
2020
Q3 | $359K | Buy |
73,699
+1,094
| +2% | +$5.97K | ﹤0.01% | 3643 |
|
|
2020
Q2 | $402K | Buy |
72,605
+61,809
| +573% | +$283K | ﹤0.01% | 3583 |
|
|
2020
Q1 | $35K | Buy |
10,796
+1
| +0% | +$5 | ﹤0.01% | 4011 |
|
|
2019
Q4 | $49K | Hold |
10,795
| – | – | ﹤0.01% | 4115 |
|
|
2019
Q3 | $45K | Hold |
10,795
| – | – | ﹤0.01% | 4132 |
|
|
2019
Q2 | $41K | Hold |
10,795
| – | – | ﹤0.01% | 4140 |
|
|
2019
Q1 | $45K | Sell |
10,795
-334
| -3% | -$1.17K | ﹤0.01% | 4105 |
|
|
2018
Q4 | $28K | Hold |
11,129
| – | – | ﹤0.01% | 4121 |
|
|
2018
Q3 | $81K | Sell |
11,129
-15,571
| -58% | -$68.2K | ﹤0.01% | 4070 |
|
|
2018
Q2 | $99K | Buy |
26,700
+13,419
| +101% | +$62.1K | ﹤0.01% | 4000 |
|
|
2018
Q1 | $51K | Buy |
13,281
+2,151
| +19% | +$9.04K | ﹤0.01% | 4168 |
|
|
2017
Q4 | $40K | Sell |
11,130
-38,516
| -78% | -$145K | ﹤0.01% | 4231 |
|
|
2017
Q3 | $196K | Sell |
49,646
-452
| -0.9% | -$2.08K | ﹤0.01% | 3882 |
|
|
2017
Q2 | $255K | Sell |
50,098
-7,826
| -14% | -$44K | ﹤0.01% | 3852 |
|
|
2017
Q1 | $400K | Buy |
57,924
+2,848
| +5% | +$22.2K | ﹤0.01% | 3647 |
|
|
2016
Q4 | $515K | Buy |
55,076
+10,202
| +23% | +$91.9K | ﹤0.01% | 3581 |
|
|
2016
Q3 | $439K | Sell |
44,874
-2,193
| -5% | -$29.6K | ﹤0.01% | 3604 |
|
|
2016
Q2 | $665K | Buy |
47,067
+2,126
| +5% | +$33.2K | ﹤0.01% | 3391 |
|
|
2016
Q1 | $629K | Buy |
44,941
+3,208
| +8% | +$47.1K | ﹤0.01% | 3323 |
|
|
2015
Q4 | $851K | Buy |
41,733
+6,304
| +18% | +$97.2K | ﹤0.01% | 3265 |
|
|
2015
Q3 | $465K | Buy |
35,429
+2,578
| +8% | +$42.8K | ﹤0.01% | 3612 |
|
|
2015
Q2 | $503K | Buy |
32,851
+8,305
| +34% | +$159K | ﹤0.01% | 3636 |
|
|
2015
Q1 | $491K | Buy |
24,546
+5,200
| +27% | +$116K | ﹤0.01% | 3613 |
|
|
2014
Q4 | $407K | Sell |
19,346
-325
| -2% | -$6.62K | ﹤0.01% | 3693 |
|
|
2014
Q3 | $367K | Buy |
19,671
+2,711
| +16% | +$49.1K | ﹤0.01% | 3725 |
|
|
2014
Q2 | $391K | Buy |
+16,960
| New | +$299K | ﹤0.01% | 3671 |
|
Bank of New York Mellon's AGTC Position: Q4 2022 in Review
Bank of New York Mellon sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 30,024 shares — an estimated $8K sold.
Bank of New York Mellon first reported a position in AGTC in Q2 2014 and held it in 34 quarters. The position peaked at $851K in Q4 2015. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Bank of New York Mellon reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Bank of New York Mellon sold 30,024 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $8K.
- Bank of New York Mellon first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 34 quarters.
- Bank of New York Mellon's Applied Genetic Technologies Corporation position peaked at $851K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.